Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionProduct descriptionProduct information

Generic, brand name and therapeutic class of product

4 evidence topics · 10 sources

Generic name, chemical name, and identifiers
FieldQuoted record
International nonproprietary name (Latin)“inaxaplinum”
International nonproprietary name (English)“inaxaplin”
Chemical name“3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N- [(3S,4R)-4-hydroxy-2-oxopyrrolidin-3-yl]propanamide”
Functional description“apolipoprotein L1 (APOL1) function inhibitor”
Molecular formula“C21H18F3N3O3”
CAS registry number“2446816-88-0”
INN list“Proposed INN: List 125”
Brand name

No evidence found.